

[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
Raghuram Selvaraju Initiated (BBIO) at Strong Buy and Held Target at $50 on, Apr 13th, 2020
Raghuram Selvaraju of HC Wainwright & Co., Initiated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $50 on, Apr 13th, 2020.
Raghuram has made no other calls on BBIO in the last 4 months.
There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $43 on, Tuesday, March 3rd, 2020
- Salim Syed of "Mizuho" Initiated at Strong Buy and Held Target at $51 on, Wednesday, February 19th, 2020